| Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial SP Mollan, JL Mitchell, RS Ottridge, M Aguiar, A Yiangou, Z Alimajstorovic, ... JAMA neurology 78 (6), 678-686, 2021 | 98 | 2021 |
| Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension CSJ Westgate, HF Botfield, Z Alimajstorovic, A Yiangou, M Walsh, G Smith, ... JCI insight 6 (10), 2021 | 51 | 2021 |
| Headache attributed to idiopathic intracranial hypertension and persistent post‐idiopathic intracranial hypertension headache: a narrative review SP Mollan, O Grech, AJ Sinclair Headache: The Journal of Head and Face Pain 61 (6), 808-816, 2021 | 46 | 2021 |
| Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension SP Mollan, BR Wakerley, Z Alimajstorovic, J Mitchell, R Ottridge, ... The journal of headache and pain 22, 1-9, 2021 | 39 | 2021 |
| Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation A Yiangou, JL Mitchell, C Fisher, J Edwards, V Vijay, Z Alimajstorovic, ... Headache: The Journal of Head and Face Pain 61 (1), 157-169, 2021 | 39 | 2021 |
| Emerging themes in idiopathic intracranial hypertension O Grech, SP Mollan, BR Wakerley, Z Alimajstorovic, GG Lavery, ... Journal of neurology 267 (12), 3776-3784, 2020 | 38 | 2020 |
| The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial JL Mitchell, HS Lyons, JK Walker, A Yiangou, O Grech, Z Alimajstorovic, ... Brain 146 (5), 1821-1830, 2023 | 35 | 2023 |
| Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure O Grech, A Clouter, JL Mitchell, Z Alimajstorovic, RS Ottridge, A Yiangou, ... Brain communications 3 (3), fcab202, 2021 | 31 | 2021 |
| The role of metabolism in migraine pathophysiology and susceptibility O Grech, SP Mollan, BR Wakerley, D Fulton, GG Lavery, AJ Sinclair Life 11 (5), 415, 2021 | 30 | 2021 |
| New horizons for idiopathic intracranial hypertension: advances and challenges SP Mollan, O Grech, Z Alimajstorovic, BR Wakerley, AJ Sinclair British medical bulletin 136 (1), 118-126, 2020 | 27 | 2020 |
| Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer … L Elliot, E Frew, SP Mollan, JL Mitchell, A Yiangou, Z Alimajstorovic, ... Surgery for Obesity and Related Diseases 17 (7), 1310-1316, 2021 | 25 | 2021 |
| Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension A Yiangou, JL Mitchell, V Vijay, O Grech, E Bilton, GG Lavery, C Fisher, ... The journal of headache and pain 21, 1-8, 2020 | 25 | 2020 |
| Nuclear magnetic resonance spectroscopy metabolomics in idiopathic intracranial hypertension to identify markers of disease and headache O Grech, SY Seneviratne, Z Alimajstorovic, A Yiangou, JL Mitchell, ... Neurology 99 (16), e1702-e1714, 2022 | 17 | 2022 |
| Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension JL Mitchell, R Buckham, H Lyons, JK Walker, A Yiangou, M Sassani, ... Fluids and Barriers of the CNS 19 (1), 85, 2022 | 13 | 2022 |
| Current perspectives on idiopathic intracranial hypertension without papilloedema SP Mollan, YJ Chong, O Grech, AJ Sinclair, BR Wakerley Life 11 (6), 472, 2021 | 12 | 2021 |
| Alterations in metabolic flux in migraine and the translational relevance O Grech, M Sassani, G Terwindt, GG Lavery, SP Mollan, AJ Sinclair The Journal of Headache and Pain 23 (1), 127, 2022 | 7 | 2022 |
| 2 IIH Pressure–a randomised, controlled, double blind physiology study of the effect of Exenatide on intracranial pressure J Mitchell, J Walker, H Lyons, K Brock, V Vijay, A Yiangou, ... BMJ Military Health 167 (3), e1-e1, 2021 | 6 | 2021 |
| Practice points for ophthalmologists from the 2020 British Society for Rheumatology Giant Cell Arteritis guidelines SP Mollan, O Grech, E O’Sullivan, SL Mackie Eye 35 (3), 699-701, 2021 | 6 | 2021 |
| Dysregulation of amino acid, lipid, and acylpyruvate metabolism in idiopathic intracranial hypertension: A non-targeted case control and longitudinal metabolomic study Z Alimajstorovic, SP Mollan, O Grech, JL Mitchell, A Yiangou, M Thaller, ... Journal of Proteome Research 22 (4), 1127-1137, 2022 | 5 | 2022 |
| A randomised controlled, trial of the GLP-1 receptor agonist exenatide in idiopathic intracranial hypertension J Mitchell, S Mollan, J Walker, H Lyons, A Yiangou, Z Alimajs-torovic, ... Journal of Neurology, Neurosurgery and Psychiatry 93 (6), A98-A98, 2022 | 5 | 2022 |
